The global white biotech market size was valued at USD 432.62 billion in 2025 and is projected to grow from USD 458.88 billion in 2026 to USD 735.26 billion by 2034, registering a CAGR of 6.07% during the forecast period from 2026 to 2034. Asia Pacific dominated the white biotech market with a market share of 36.4% in 2025. Growing demand for sustainable manufacturing, bio-based chemicals, and renewable industrial materials is supporting the adoption of white biotechnology across several industries.

• Market Size (2025): USD 432.62 billion

• Market Size (2026): USD 458.88 billion

• CAGR (Forecast Period): 6.07% (2026–2034)

• Forecast Year: 2034

• Projected Market Size (Forecast Year): USD 735.26 billion

• Dominant Region: Asia Pacific (36.4% share in 2025)

• Fastest Growing Region: Not specified in the available market data.

White Biotech Market Overview

White biotechnology, also known as industrial biotechnology, uses microorganisms, enzymes, and biological processes to manufacture products for industrial applications. It offers alternatives to conventional chemical production by using biological systems to develop bio-based chemicals, fuels, materials, and other industrial products.

The market is gaining attention as manufacturers seek production methods that reduce dependence on fossil-based raw materials and improve resource efficiency. Applications across chemicals, food and beverages, pharmaceuticals, agriculture, textiles, and bioenergy are expanding the commercial relevance of white biotechnology. Advances in fermentation, enzyme engineering, and synthetic biology are also improving the range of industrial processes that can use biological solutions.

Growth Drivers of the White Biotech Market

The increasing demand for sustainable industrial production is a major factor driving the white biotech market. Manufacturers are exploring bio-based alternatives to conventional chemicals and petroleum-derived materials to reduce environmental impact and support sustainability targets. Enzymes and microbial processes can help improve production efficiency in applications such as detergents, food processing, textiles, and specialty chemicals.

Government initiatives supporting bio-based economies and renewable resources are also encouraging market development. Funding for biotechnology research, industrial innovation, and low-carbon manufacturing is creating opportunities for companies to commercialize new processes. Corporate sustainability commitments and demand for products with lower environmental footprints further support the adoption of industrial biotechnology.

Challenges in the White Biotech Market

High research and development costs remain a challenge for the white biotech industry. Developing commercially viable enzymes, microorganisms, and fermentation processes requires specialized expertise, advanced laboratory infrastructure, and significant investment. Scaling laboratory innovations to industrial production can also involve technical and financial difficulties.

Feedstock availability and production economics may affect the competitiveness of bio-based products. Agricultural residues, sugars, and other biological raw materials can vary in price and availability depending on regional supply conditions. In addition, established petrochemical production systems benefit from mature infrastructure and economies of scale, making it difficult for some bio-based alternatives to compete on price.

Opportunities in the White Biotech Market

Advances in synthetic biology, metabolic engineering, and enzyme development are creating opportunities for new industrial applications. These technologies can help improve microorganism performance, optimize biological production pathways, and enable the development of specialized bio-based chemicals and materials. Continued innovation may also improve process efficiency and reduce manufacturing costs.

The growing interest in circular manufacturing offers another opportunity for market participants. Industrial biotechnology can convert agricultural residues, food waste, and other renewable feedstocks into useful products, supporting resource recovery and waste reduction. Partnerships between biotechnology companies, chemical manufacturers, and agricultural suppliers can accelerate commercialization and strengthen bio-based supply chains.

White Biotech Market Segment Analysis

The white biotech market includes products and technologies such as enzymes, bio-based chemicals, biofuels, and other biologically produced industrial materials. Industrial enzymes are used in applications including detergents, food processing, animal feed, textiles, and pulp and paper manufacturing. Their ability to support specific chemical reactions under controlled conditions makes them valuable for improving production processes.

Bio-based chemicals and materials are also important market categories, with applications across packaging, agriculture, personal care, and industrial manufacturing. Fermentation and other biological production methods enable the conversion of renewable feedstocks into commercially useful compounds. End-use industries such as chemicals, food and beverages, pharmaceuticals, energy, and agriculture contribute to demand for white biotechnology solutions.

Regional Analysis of the White Biotech Market

Europe represents an established market supported by sustainability policies, circular economy initiatives, and investment in industrial biotechnology. Countries such as Germany, France, and the Netherlands are advancing bio-based chemicals, enzyme applications, and renewable industrial materials. The region's focus on reducing fossil resource dependence supports demand for biotechnology-based production methods.

North America benefits from strong biotechnology research capabilities, established chemical and pharmaceutical industries, and investment in bio-based product development. The United States and Canada are supporting innovation in fermentation, synthetic biology, and renewable feedstock processing.

Latin America and the Middle East and Africa also present opportunities for white biotechnology adoption. Agricultural resources, biofuel production, and increasing interest in sustainable industrial processes can support market development. Improvements in technology access and manufacturing infrastructure will influence the pace of adoption across these regions.

Competitive Landscape of the White Biotech Market

The white biotech market includes biotechnology companies, industrial enzyme manufacturers, chemical producers, and bio-based material developers. Competition is shaped by product performance, production efficiency, research capabilities, intellectual property, and access to renewable feedstocks. Companies are investing in enzyme innovation, fermentation technologies, and strategic collaborations to expand their industrial biotechnology portfolios.

Key companies operating in the white biotech market include:

• Novonesis

• BASF SE

• DSM-Firmenich

• DuPont de Nemours, Inc.

• Evonik Industries AG

• Cargill, Incorporated

• Archer Daniels Midland Company

• International Flavors & Fragrances Inc.

• LanzaTech Global, Inc.

• Genomatica, Inc.

Recent Developments in the White Biotech Market

Recent industry activity reflects increasing investment in enzyme engineering, synthetic biology, and the commercial production of bio-based chemicals. Biotechnology developers are working with industrial manufacturers to improve fermentation processes and develop biological alternatives for established chemical applications.

Companies are also exploring the use of agricultural residues and industrial waste as feedstocks for bio-based production. These initiatives aim to improve resource efficiency and support circular manufacturing models. Collaborations between research institutions, biotechnology firms, and large industrial companies are helping move new technologies from research into commercial applications.

Future Outlook of the White Biotech Market

Advances in synthetic biology, fermentation, and enzyme engineering may improve production efficiency and expand the range of commercially viable applications. However, cost competitiveness, feedstock availability, and the ability to scale production will remain important factors influencing adoption. Continued investment and collaboration across biotechnology and manufacturing industries are expected to shape the market's long-term progress.

Click to Read the Complete Insights & Report: https://straitsresearch.com/report/white-biotech-market

About Straits Research

Straits Research is a global market intelligence and consulting company that provides comprehensive market analysis, industry insights, and strategic research solutions. The company helps businesses, investors, and industry stakeholders understand market trends, evaluate growth opportunities, and make informed business decisions through data-driven research and actionable insights.